Publication: Cutaneous adverse reactions to sulfonamide antibiotics
Issued Date
2011-09-26
Resource Type
ISSN
22288694
0125877X
0125877X
Other identifier(s)
2-s2.0-80053008561
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.29, No.3 (2011), 284-289
Suggested Citation
Weeranut Chantachaeng, Leena Chularojanamontri, Kanokvalai Kulthanan, Kowit Jongjarearnprasert, Nuruemon Dhana Cutaneous adverse reactions to sulfonamide antibiotics. Asian Pacific Journal of Allergy and Immunology. Vol.29, No.3 (2011), 284-289. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/11991
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cutaneous adverse reactions to sulfonamide antibiotics
Other Contributor(s)
Abstract
Background: Sulfonamides are divided into two main groups which are sulfonamide antibiotics and sulfonamide non-antibiotics. The wide use of sulfonamide antibiotics leads to increasing incidence of sulfonamide cutaneous reactions. Objective: The purpose of this study is to explore the cutaneous manifestations induced by sulfonamide antibiotics in a large number of Thai patients, including human immunodeficiency virus (HIV) and non-HIV infected individuals. The second purpose is to determine the risk factors for development of sulfonamide cutaneous reactions. Methods: We retrospectively studied 191 patients with sulfonamide antibiotics cutaneous reactions attending the adverse drug reaction center, Siriraj Hospital, Bangkok between 2006 and 2010. Results: Majority of the patients was female (59.7%).Maculopapular rash was the most common cutaneous manifestation (37.7%), followed by fixed drug eruption (22%), angioedema with or without urticaria (12.6%) and urticaria alone (12%). Among those with known HIV serology, maculopapular eruption occurred more frequently in the HIV positive group while fixed drug eruption occurred more frequently in HIV-negative group. Conclusion: From our study, there were no significant determination factors to develop serious drug reactions. However, the HIVpositive status and lower level of CD4 count had a tendency to increase risk of developing serious cutaneous reactions.
